4BASEBIO UK SOCIETAS (4BB) — Cash Flow-to-Debt Ratio
4BASEBIO UK SOCIETAS (4BB) has a Cash Flow-to-Debt Ratio of -0.43x as of June 2025, meaning its operating cash flow of GBX-7.64 Million could theoretically repay 0% of its total liabilities (GBX17.89 Million) in one year. See 4BASEBIO UK SOCIETAS short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
4BASEBIO UK SOCIETAS Cash Flow-to-Debt Ratio (2019–2024)
Historical debt coverage capacity for 4BASEBIO UK SOCIETAS across 6 annual periods. Also explore 4BASEBIO UK SOCIETAS net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for 4BASEBIO UK SOCIETAS (2019–2024)
Year-by-year debt coverage analysis for 4BASEBIO UK SOCIETAS. For market capitalisation and broader financial context, see 4BASEBIO UK SOCIETAS stock valuation.
| Year | CF-to-Debt Ratio | Operating CF (GBX) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.59x | GBX-10.74 Million | GBX18.35 Million | ▼ -17.7% |
| 2023 | -0.50x | GBX-6.18 Million | GBX12.41 Million | ▲ +51.7% |
| 2022 | -1.03x | GBX-4.70 Million | GBX4.57 Million | ▼ -13.0% |
| 2021 | -0.91x | GBX-2.74 Million | GBX3.01 Million | ▼ -109.6% |
| 2020 | -0.43x | GBX-1.02 Million | GBX2.35 Million | ▼ -392.1% |
| 2019 | -0.09x | GBX-269.00K | GBX3.04 Million | — |